An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants
| Status: | Completed |
|---|---|
| Conditions: | Psoriasis |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 8/3/2018 |
| Start Date: | March 5, 2018 |
| End Date: | May 4, 2018 |
An Open-Label, Single-Sequence Study to Investigate the Effects of Cyclosporine on the Pharmacokinetics of BMS-986165 at Steady State in Healthy Male Participants
This is an investigational study of Cyclosporine on the experimental medication BMS-986165 in
healthy male participants.
healthy male participants.
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please
visit www.BMSStudyConnect.com
Inclusion Criteria:
- Healthy participant, as determined by no clinically significant deviation from normal
in medical history, physical examination, ECGs, and clinical laboratory determinations
- Body mass index 18.0 to 32.0 kg/m2
- Weight ≥ 50 kg
Exclusion Criteria:
- Any medical condition that presents a potential risk to the subject and/or may
compromise the objectives of the study, including a history of or active liver disease
- History or presence of acute or chronic bacterial, fungal, or viral infection (eg,
pneumonia, septicemia) within the 3 months prior to screening
- Known or suspected autoimmune disorder, or any history of known or suspected
congenital or acquired immunodeficiency state or condition that would compromise the
participant's immune status
- History of administration of live vaccines within 60 days before screening
- Any history or risk for tuberculosis (TB)
Other protocol defined inclusion/exclusion criteria could apply
We found this trial at
1
site
Click here to add this to my saved trials
